IDiyas

For the Inventor, By the Inventor

Ste-Foy, Canada

Yves M Merand

USPTO Granted Patents = 15

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 275(Granted Patents)


Location History:

  • Ste.-Foy, CA (1996)
  • Quebec, CA (1993 - 2000)
  • Ste-Foy, CA (1993 - 2000)
  • Sainte-Foy, CA (2003)

Company Filing History:

goldMedal14 out of 80 
 
Endorecherche, Inc.
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1993-2003

Loading Chart...
15 patents (USPTO):Explore Patents
1. 6541463 - Inhibitors of type 5 and type 3 17&bgr;-hydroxysteroid dehydrogenase and methods for their use (2003-04-01),
2. 6110906 - Androgen derivatives for use in the inhibition of sex steroid activity (2000-08-29),
3. 6060503 - Benzopyran-containing compounds and method for their use (2000-05-09),
4. 6015806 - Antiandrogens (2000-01-18),
5. 5879711 - Stable antiandrogenic gel composition (1999-03-09),
6. 5840735 - Sex steroid activity inhibitors (1998-11-24),
7. 5686465 - Sex steroid activity inhibitors (1997-11-11),
8. 5686437 - Estrogen nucleus derivatives for use in the inhibition of sex steroid (1997-11-11),
9. 5585405 - Inhibitors of sex steroid biosynthesis and methods for their production (1996-12-17),
10. 5494914 - Inhibitors for testosterone 5.alpha.-reductase activity (1996-02-27),
11. 5395842 - Anti-estrogenic compounds and compositions (1995-03-07),
12. 5393785 - Therapeutic antiestrogens (1995-02-28),
13. 5364847 - Inhibitors of sex steroid biosynthesis and methods for their production (1994-11-15),
14. 5227375 - Aromatase inhibitors (1993-07-13),
15. 5204337 - Estrogen nucleus derivatives for use in inhibition of sex steroid (1993-04-20),

Title: Yves M Merand: Innovator in Medical Treatments

Introduction

Yves M Merand is a notable inventor based in Ste-Foy, Canada. He has made significant contributions to the field of medical treatments, particularly through his innovative patents. With a total of 15 patents to his name, Merand has focused on developing methods that address diseases sensitive to androgenic or estrogenic activity.

Latest Patents

Among his latest patents are inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase. These patents disclose novel methods for medical treatment and inhibition of disease development. The treatments utilize inhibitors that target these specific enzymes, which play a crucial role in steroid metabolism. Additionally, he has developed androgen derivatives aimed at treating sex steroid-dependent diseases. These compounds function by inhibiting sex steroid synthesis and blocking androgen receptors, showcasing his innovative approach to medical challenges.

Career Highlights

Throughout his career, Yves M Merand has worked with various companies, including Endorecherche, Inc. His work has significantly impacted the development of treatments for diseases related to hormonal imbalances. His extensive research and patent portfolio reflect his dedication to advancing medical science.

Collaborations

Merand has collaborated with notable individuals in the field, including Fernand Labrie and Shankar Mohan Singh. These partnerships have further enhanced his research and development efforts, leading to groundbreaking innovations.

Conclusion

Yves M Merand's contributions to medical treatments through his patents demonstrate his commitment to improving health outcomes. His innovative work continues to influence the field and offers promising solutions for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…